证券代码：600596 证券简称：新安股份 公告编号：2025-062号 浙江新安化工集团股份有限公司 关于公司开立募集资金专项账户并签订募集资金专户存储 四方监管协议的公告 1.甲方已在乙方开设募集资金专项账户（以下简称"专户"），账户为3个月可转让大额存单。该专户仅 用于甲方二浙江开化合成材料有限公司搬迁入园提升项目部分募集资金的现金管理，不得用作其他用 途， 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意浙江新安化工集团股份有限公司向特定对象发行股票注册的批 复》（证监许可〔2023〕1342号），公司采用网下向配售对象询价配售方式，向特定对象发行人民币普 通股203,850,509股，发行价为每股人民币8.83元，共计募集资金1,799,999,994.47元，扣除承销和保荐费 用16,037,735.81元后的募集资金为1,783,962,258.66元，已于2023年11月30日汇入公司募集资金监管账 户。另减除审计及验资费用、律师费用、股权登记费等 ...

Core Viewpoint - The company announced the approval of a proposal to use excess and idle raised funds for cash management, focusing on low-risk financial products with high safety and liquidity [1] Group 1 - The company will utilize up to 500 million yuan of temporarily idle raised funds for cash management [1] - The investment will be in low-risk financial products that are safe and have good liquidity [1] - The usage period for these funds is valid for 12 months from the date of board approval [1] Group 2 - The company stated that this action will not affect the progress of the investment projects funded by the raised capital or the normal production and operation of the company [1]

Core Viewpoint - The company announced that it raised a net amount of 917 million yuan from its initial public offering, with plans for cash management using idle funds [1] Group 1: Fundraising and Investment - The actual net amount raised from the IPO is 917 million yuan [1] - As of October 31, 2025, the company has invested a total of 280 million yuan in committed investment projects, achieving an investment progress of 67.49% [1] - The company has allocated 300 million yuan from the excess raised funds [1] Group 2: Cash Management Plan - Due to some of the raised funds being temporarily idle, the company plans to use up to 200 million yuan of excess and idle funds for cash management [1] - The cash management period will last for 12 months from the approval of the shareholders' meeting and can be used in a revolving manner [1] - The products for cash management are characterized by high safety and good liquidity, and they cannot be pledged [1] Group 3: Approval Process - The cash management plan has been approved by the board of directors but still requires approval from the shareholders' meeting [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 截至2025年11月11日，公司间接控股股东天津泰达投资控股（集团）有限公司持有渤海银行股份有限公 司20.34%的股权，为渤海银行股份有限公司第一大股东，根据《深圳证券交易所股票上市规则》第 6.3.3条的相关规定，渤海银行股份有限公司为公司的关联方，公司与渤海银行股份有限公司发生的交 易，构成公司的关联交易。 二、关联方基本情况 公司名称：渤海银行股份有限公司 法定代表人：王锦虹 住所：天津市河东区海河东路218号渤海银行大厦 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 天津力生制药股份有限公司（以下简称"公司"）于2025年3月19日召开第七届董事会第五十次会议、 2025年4月11日召开2024年度股东大会，审议通过了《关于公司2025年使用闲置自有资金进行现金管理 额度的议案》《关于公司2025年度现金管理暨关联交易额度的议案》，同意公司使用额度不超过人民币 10亿元闲置自有资金购买安全性高、流动性好、主要由大型商业银行或证券机构发行的短期理财产品， 包括但不限于通过银行、证券等专业理财机构购买的 ...

Core Viewpoint - The company plans to utilize up to RMB 710 million of temporarily idle raised funds for cash management, investing in principal-protected cash management products such as time deposits [1] Group 1 - The board of directors will hold the 31st meeting of the 9th session on November 11, 2025, to review the cash management proposal [1] - The approved cash management amount is valid for 12 months from the date of board approval, allowing for rolling use within the limit [1] - The company assures that this decision will not affect the progress of the investment projects funded by the raised capital or the normal production and operation of the company [1]

Core Viewpoint - The company is engaging in cash management to generate investment returns, thereby providing greater investment returns for the company and its shareholders [2] Summary by Relevant Categories - **Company Strategy** - The company is focused on cash management as a means to achieve investment income [2] - **Investment Returns** - The initiative aims to enhance investment returns for both the company and its shareholders [2]

Core Viewpoint - The company has made significant governance changes, including the cancellation of the supervisory board, amendments to its articles of association, and a capital increase, which are aimed at enhancing operational efficiency and aligning with its new status as a publicly listed company [2][43]. Group 1: Board Meeting and Resolutions - The first board meeting of the company was held on November 10, 2025, with all five directors present, confirming the legality of the meeting [1][4]. - The board approved the cancellation of the supervisory board and the amendment of various governance documents, which will take effect upon shareholder approval of the new board election [2][44]. - The board also approved a capital increase from RMB 384.529321 million to RMB 437.029321 million, changing the company type to "publicly listed company" [7][45]. Group 2: Governance Changes - The company confirmed the cancellation of the supervisory board, with its functions being transferred to the audit committee of the board [46]. - Amendments to the articles of association and other governance documents were approved, which will take effect after the election of the new board [48][49]. Group 3: Board Elections - The board proposed candidates for the second board, including three non-independent directors and two independent directors, pending shareholder approval [9][14]. - The voting results for the nominations were unanimous in favor, with no objections [10][16]. Group 4: Financial Management - The company plans to use RMB 274.45 million of raised funds to replace pre-invested self-raised funds in projects and RMB 8.75 million for issuance costs, complying with regulations [21][34]. - The total amount raised from the public offering was RMB 896.7 million, with a net amount of RMB 803.16 million after deducting issuance costs [34][44]. Group 5: Capital Expenditure and Projects - The board approved a capital expenditure plan of RMB 300 million for the period until December 31, 2026, focusing on fixed asset procurement and improvements [28]. - The company will invest in an AI computing high-end printed circuit board expansion project, with the authority to manage the project delegated to the general manager [25].

Core Viewpoint - The company plans to utilize idle self-owned funds for cash management, with a total amount not exceeding 600 million RMB, approved by the board and shareholders, to enhance fund efficiency and generate returns without affecting daily operations [2][4][15]. Investment Overview - **Investment Purpose**: The company aims to effectively utilize temporarily idle self-owned funds to increase fund efficiency and returns while ensuring normal operational cash flow and risk control [4]. - **Investment Amount**: The cash management investment amount is set at 70 million RMB [5]. - **Source of Funds**: The funds for this cash management initiative will come from the company's idle self-owned funds [6]. - **Investment Method and Duration**: The company will purchase structured deposits from Zheshang Bank with a term of 182 days, within the authorized limit [7]. Review Procedures - The company held meetings on April 25, 2025, and a shareholder meeting on May 19, 2025, to approve the cash management proposal, allowing for a maximum of 600 million RMB to be used for this purpose [8][9]. Investment Risk Analysis and Control Measures - **Risk Analysis**: Despite thorough evaluations of financial products, market fluctuations and macroeconomic factors may impact investment returns [10][11]. - **Risk Control Measures**: The company will not use idle funds for securities investments or purchase unsecured bond products, adhering to prudent investment principles and selecting reputable financial institutions [12][13]. Independent directors and the audit committee will oversee fund usage [13]. Impact on the Company - The cash management amount represents 19.93% of the company's cash at the end of the most recent period, which is expected to enhance fund efficiency without affecting daily operations or the development of core business [15]. The management of cash will comply with new financial instrument standards, potentially impacting financial statements [15].

Financial Data and Key Metrics Changes - Sales for Q3 2025 were $374 million, a decrease of approximately 6% compared to the prior year, primarily due to softer demand in chemical intermediates and nylon end markets [8][9] - Adjusted EBITDA was $25 million, down $28 million from last year, with an adjusted EBITDA margin of 6.6% [8][9] - Free cash flow for the trailing 12 months through Q3 2025 is approximately break-even, with a target for positive free cash flow for the full year of 2025 [14][15] Business Line Data and Key Metrics Changes - Plant nutrients showed strong performance, with a year-over-year pricing increase in the fall fill program, while nylon solutions faced pressure with moderated production rates [10][11] - Granular ammonium sulfate volume was up 20% year-over-year, contributing to record revenue for the segment in Q3 [28] - Acetone pricing moderated from multi-year highs, impacting overall chemical intermediates performance [10][12] Market Data and Key Metrics Changes - The agricultural and fertilizer market continues to grow, with sulfur nutrition demand expected to increase by 3-4% per year [11] - The building construction market remains stable, while the plastics sector faces broader macro softness [12] - Demand in the semiconductor space is anticipated to improve sequentially into Q4 and 2026 [12] Company Strategy and Development Direction - The company is focused on optimizing operational performance and cash management, with a disciplined approach to capital investment [6][16] - Strategic initiatives include leveraging a low-cost position in vertically integrated production and enhancing capabilities in ammonium sulfate growth [16][17] - The company is positioned to navigate cycles and capitalize on emerging opportunities, with a focus on long-term value creation [16][52] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenging industry dynamics and the need to moderate production rates due to demand softness [4][5] - The company expects strong free cash flow in Q4, supported by working capital tailwinds [14] - There is confidence in capturing significant benefits from the 45Q carbon capture tax credits, although timing may shift to 2026 due to government processes [33][34] Other Important Information - A site-wide electrical outage at the Chesterfield nylon plant had minimal impact on Q3 results but is expected to affect Q4 EBITDA by $7-$9 million [5] - The company successfully completed a planned plant turnaround at the Hopewell facility [5] - Two new members were added to the board of directors, enhancing corporate governance and strategic growth priorities [7] Q&A Session Summary Question: Insights on the chemical intermediates market and pricing environment - Management indicated that acetone represents roughly 50% of sales in chemical intermediates, with subdued phenol demand impacting overall results [21][22] Question: Update on ammonium sulfate results - The company reported the highest third-quarter revenue for ammonium sulfate, driven by increased granular volume and favorable pricing [27][28] Question: Raw material cost trends and purchasing strategies - Management noted that they typically do not execute hedges on raw materials, with natural gas prices increasing significantly year-over-year [30][31] Question: Update on Section 45Q carbon capture credits - The company expects to receive credits in 2026 due to delays from the government shutdown, with a cumulative benefit anticipated across the program's life [33][34] Question: Impact of bonus depreciation on financial results - Bonus depreciation primarily affects the cash tax rate, with significant benefits expected in future years as more projects qualify [35][36] Question: Cost reduction initiatives for 2026 - Management highlighted a focus on productivity and addressing non-manpower fixed costs as part of their cost reduction strategy [41][42] Question: Nature of the settlement regarding intellectual property - The settlement included a monetary component and established a customer base that respects the company's intellectual property rights [45][46]

Core Viewpoint - Haohai Biological Technology (06826) announced plans to enhance the efficiency of raised funds by utilizing a portion of temporarily idle funds for cash management, aiming to increase company income and shareholder returns [1] Fund Utilization - The company plans to use no more than RMB 300 million (including the principal) of temporarily idle raised funds for cash management [1] - The usage period for these funds is effective for 12 months from the date of board approval [1] - Within the specified limit and timeframe, the funds can be used in a rolling manner [1]